Atea Pharmaceuticals (AVIR) Shares Issued (2020 - 2022)

Historic Shares Issued for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $140000.0.

  • Atea Pharmaceuticals' Shares Issued fell 8238.99% to $140000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $363000.0, marking a year-over-year decrease of 7522.18%. This contributed to the annual value of $267000.0 for FY2024, which is 389.11% up from last year.
  • Latest data reveals that Atea Pharmaceuticals reported Shares Issued of $140000.0 as of Q3 2022, which was down 8238.99% from $223000.0 recorded in Q1 2022.
  • In the past 5 years, Atea Pharmaceuticals' Shares Issued registered a high of $317.6 million during Q4 2020, and its lowest value of $57000.0 during Q2 2021.
  • Its 3-year average for Shares Issued is $45.6 million, with a median of $223000.0 in 2022.
  • As far as peak fluctuations go, Atea Pharmaceuticals' Shares Issued crashed by 9995.53% in 2021, and later plummeted by 5265.39% in 2022.
  • Over the past 3 years, Atea Pharmaceuticals' Shares Issued (Quarter) stood at $317.6 million in 2020, then tumbled by 99.96% to $142000.0 in 2021, then fell by 1.41% to $140000.0 in 2022.
  • Its last three reported values are $140000.0 in Q3 2022, $223000.0 for Q1 2022, and $142000.0 during Q4 2021.